AMENDED AND RESTATED LICENSE AND EXPANDED COLLABORATION AGREEMENTLicense and Collaboration Agreement • November 6th, 2012 • Amicus Therapeutics Inc • Pharmaceutical preparations • Delaware
THIS AMENDED AND RESTATED LICENSE AND EXPANDED COLLABORATION AGREEMENT (the “Agreement”) is made as of the 17th day of July, 2012 (the “Restatement Effective Date”) by and between Amicus Therapeutics, Inc., a Delaware corporation having a place of business at 1 Cedar Brook Drive, Cranbury, New Jersey, 08512 (“Amicus”) and Glaxo Group Limited, a company organized under the laws of England and Wales with its registered office address at Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex, UB6 0NN, England (“GSK”). Amicus and GSK are each referred to herein by name or as a “Party” or, collectively, as the “Parties”.
STOCK PURCHASE AGREEMENTStock Purchase Agreement • November 6th, 2012 • Amicus Therapeutics Inc • Pharmaceutical preparations • Delaware
THIS STOCK PURCHASE AGREEMENT (this “Agreement”) is made as of the 17th day of July, 2012 (the “SPA Effective Date”) by and between Amicus Therapeutics, Inc. (“Amicus”), a Delaware corporation with its principal place of business at 1 Cedar Brook Drive, Cranbury, New Jersey 08512, and Glaxo Group Limited, a company organized under the laws of England and Wales with its registered office address at Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex, UB6 0NN, England (“GSK”). Amicus and GSK are each referred to herein by name or as a “Party” or, collectively, as the “Parties”.
